AKTX

Akari Therapeutics (AKTX)

About Akari Therapeutics (AKTX)

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Details

Daily high
$11.79
Daily low
$10.56
Price at open
--
52 Week High
$49.60
52 Week Low
$3.02
Market cap
12.9M
Dividend yield
0.00%
Volume
30
Avg. volume
350,064
P/E ratio
-.04

Akari Therapeutics News

Details

Daily high
$11.79
Daily low
$10.56
Price at open
--
52 Week High
$49.60
52 Week Low
$3.02
Market cap
12.9M
Dividend yield
0.00%
Volume
30
Avg. volume
350,064
P/E ratio
-.04